Skip to main content
. 2012 May 1;3(3):138–150. doi: 10.6004/jadpro.2012.3.3.2

Table 1.

Table 1

Table 1. Epidermal Growth Factor Receptor and Multikinase Inhibitors: Associated Dermatologic Adverse Events